MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617009241 A) filed by Crispr Therapeutics AG on January 29, 2026, for Modulating Expression Of Alas1 (5'-Aminolevulinate Synthase 1) Gene.
Inventors include Dequeant, Mary-Lee; Heath, Heidi; and Yuen, Rachel.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present disclosure relates to methods, compositions and kits for treating conditions that are related to the modulation of expression of 5'-Aminolevulinate Synthase 1 (ALAS1) by gene editing.
Disclaimer: Curated by HT Syndication....